Expression pattern of the bcl-2 homologous protein bad in normal skin, psoriasis vulgaris and keratinocytic tumors

Journal of Dermatological Science

Volumn 22, Issue 2, 2000, Pages 132-137

  Tomková, Hana ^a   Fujimoto, Wataru ^a   Arata, Jirô ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Bad; Bcl 2 family; Non melanoma skin cancer; Psoriasis vulgaris; Skin disease

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PSORIASIS VULGARIS; SKIN CANCER; SKIN DISEASE; SQUAMOUS CELL CARCINOMA;

BCL-ASSOCIATED DEATH PROTEIN; CARRIER PROTEINS; CELL DEATH; HUMANS; KERATINOCYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; PSORIASIS; SKIN; SKIN NEOPLASMS;

EID: 0033992139     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(99)00058-4     Document Type: Article

References (20)

1. Raskin C.A. Apoptosis and cutaneous biology. J. Am. Acad. Dermatol. 36:1997;885-896.
2. Norris D.A. Differential control of cell death in the skin. Arch. Dermatol. 131:1995;945-948.
3. White E. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1996;1-15.
4. Strasser A., Huang D.C.S., Vaux D.L. The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy. Biochim. Biophys. Acta. 1333:1997;F151-F178.
5. Cha D.T., Korsmeyer S.J. Bcl-2 family: regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
6. Reed J.C., Jurgensmeier J.M., Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta. 1366:1998;127-137.
7. Susin S.A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta. 1366:1998;151-165.
8. Kitada S., Krajewski S., Myers T.G., Johnson G.C., Sausville E.A., Reed J.C. Expression and location of pro-apoptotic bcl-2 family protein bad in normal human tissues and tumor cell lines. Am. J. Pathol. 152:1998;51-61.
9. Adams J.M., Cory S. The bcl-2 protein family: arbiters of cell survival. Science. 281:1998;1322-1326.
10. Zamzami N., Brenner C., Marzo I., Susin S.A., Kroemer G. Subcellular and submitochondrial mode of action of bcl-2-like oncoproteins. Oncogene. 16:1998;2265-2282.
11. Franke T.F., Cantley L.C. A bad kinase makes good. Nature. 390:1997;116-117.
12. Basu S., Bayoumy S., Zhang Y., Lozano J., Kolesnick R. Bad enables ceramide to signal apoptosis via ras and raf-1. J. Biol. Chem. 46:1998;30419-30426.
13. Tomková H., Fujimoto W., Arata J. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur. J. Dermatol. 8:1998;256-260.
14. Tomková H., Fujimoto W., Arata J. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases. Br. J. Dermatol. 137:1997;703-708.
15. Wrone-Smith T., Johnson T., Nelson B., Boise L.H., Thompson C.B., Nunez G., Nickoloff B.J. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am. J. Pathol. 146:1995;1079-1088.
16. Cerroni L., Kerl H. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic growth in cutaneous basal-cell carcinoma. J. Cutan. Pathol. 21:1994;398-403.
17. Verhaegh M.E.J.M., Sanders C.J.G., Arends J.W., Neumann H.A.M. Expression of the apoptosis suppressing protein bcl-2 in non-melanoma skin cancers. Br. J. Dermatol. 132:1995;740-744.
18. Morales-Ducret C.R.J., van de Rijn M., LeBrun D.P., Smoller B.R. Bcl-2 expression in primary malignancies of the skin. Arch. Dermatol. 131:1995;909-912.
19. Sleater J.P., Beers B.B., Stephens C.A., Hendricks J.B. Keratoacanthoma: a deficient squamous cell carcinoma? Study of bcl-2 expression. J. Cutan. Pathol. 21:1994;514-519.
20. Wikonkal N.M., Berg R.J.M., van Haseln C.W., Horkay I., Remenyik E., Begany A., Hunyadi J., van Vloten W.A., de Gruijl F.R. Bcl-2 vs p53 protein expression and apoptotic rate in human nonmelanoma skin cancers. Arch. Dermatol. 133:1997;599-602.